Bharat Biotech's Covid nasal vaccine phase 3 trials completed

DNA

19 Jun 2022 0 shares 3 views

DNA

Published 19 Jun 2022

The company will submit its data to the Drugs Controller General of India (DCGI) next month, said Dr Krishna Ella, Bharat Biotech chief.

Bharat Biotech`s Covid-19 nasal vaccine phase III trials completed

"If everything is okay, then we will get permission to launch and it will be the world's first clinically proven nasal Covid-19..

Zee News 19 Jun 2022

In an exclusive interview with ANI, Dr Ella said, "We just completed a clinical trial, a data analysis is going on. Next month, we..

IndiaTimes 19 Jun 2022